Advanced Search

 

Study ID Status Title Patient Level Data
112321 Completed Special Drug Use Investigation for Relenza (Pediatrics resistance)
112322 Completed Drug Use Investigation for Imigran injection
112323 Completed Special Drug Use Investigation for VALTREX (valaciclovir) (Pediatrics Chickenpox)
112324 Completed Drug Use Investigation for IMIGRAN Tablet
112325 Completed Special Drug Use Investigation for Zovirax cream
112326 Completed Drug Use Investigation for Imigran® Intranasal
112327 Completed Special Drug Use Investigation for Valtrex (Adult Chickenpox)
112328 Completed Drug Use Investigation for SEREVENT ROTADISK
112329 Completed Special Drug Use Investigation for Serevent® (Long-term:asthma)
112330 Completed Drug Use Investigation for Epzicom tablet (HRD Cooperative Investigation)
112331 Completed Drug Use Investigation of Zefix Tablets
112332 Completed Special Drug Use Investigation for Serevent (Long-term:COPD)
112333 Completed Special Use Investigation of Zefix Tablets
112335 Completed Special Drug Use Investigation for ZEFIX (lamivudine) tablet (HBV Cirrhosis)
112338 Completed Special Drug Use Investigation for Serevent (COPD)
112339 Completed Special Drug Use Investigation for SEREVENT 50 DISKUS (with FLUTIDE:asthma)
112341 Completed A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects with Systemic Lupus Erythematosus (SLE)
112344 Completed Drug Use Investigation for IMURAN tablet (heart transplant)
112346 Completed Special Drug Use Investigation for Lexiva tablet (Pregnancy) (HRD Cooperative Investigation)
112348 Completed Special Drug Use Investigation for EPZICOM® (abacavir sulfate/lamivudine) tablet (Pregnancy) (HRD Cooperative Investigation)
112349 Completed Special Drug Use Investigation for Botox injection (hemi-prosopospasm)
112351 Completed Special Drug Use Investigation for SEREVENT50 DISKUS (with FLUTIDE:asthma)
112352 Completed A 12-week Study to Evaluate the 24-hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg once daily Compared with Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg twice daily in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
112353 Completed Study to evaluate the safety and reactogenicity of the HIV Vaccine 732461 in HIV infected subjects aged 18 to 55 years old
112355 Completed A Randomized, Double-Blind, Parallel-Group, 16-Week Study to Evaluate the Effect of Fluticasone Propionate/Salmeterol DISKUS® 250/50mcg BID and Placebo on Arterial Stiffness in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.